Clinical trials
Completed Observational Retinal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 7 |
| Bayer | 4 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Nidek Co. LTD. | 2 |
| Retina Institute of Hawaii | 2 |
| Topcon Medical Systems, Inc. | 2 |
| Ali Aminian | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Association for Innovation and Biomedical Research on Light and Image | 1 |
| Astellas Institute for Regenerative Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Diseases | 57 |
| Diabetes Mellitus | 10 |
| Diabetic Retinopathy | 10 |
| Glaucoma | 9 |
| Eye Diseases | 7 |
| Macular Degeneration | 7 |
| Corneal Diseases | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Macular Edema | 3 |
| Retinopathy of Prematurity | 3 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.